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ABSTRACT: Hetero-nanoparticles (H-NPs) consisting of conjugates characterized by a squalene tail linked to doxorubicin and 
ecdysteroid derivatives are presented. Biological evaluation on A2780ADR cell line confirms not only the maintenance of the activ-
ity of the parental drug but also the ability to overcome cancer resistance. The in vitro cell uptake was demonstrated and the in-
volvement of an endosomal-mediated pathway was suggested.  
The formation of self-assembled nanoparticles (NPs) using 
anticancer drug conjugates could be a useful and smart ap-
proach to face cancer.1-3 In the last few years, we developed a 
step-by-step project that moved from the preparation of a nov-
el class of squalene-conjugates with paclitaxel, podophyllotox-
in, camptothecin and epothilone A4 and reached, as highest 
evidence of efficacy, the preparation of hetero-nanoparticles 
with doxorubicin and cyclopamine conjugates that were able 
to reduce in vivo the tumour growth and toxicity due to the use 
of the single drugs.5-8 The conjugates were characterized by a 
squalene tail that makes them able to self-assemble in water, 
and by a drug unit connected via a disulfide-containing linker 
to secure the release inside the cell. 
Our interest in facing the resistance of different kind of tumor 
cells,9 drove us to consider the formation of self-assembled 
hetero nanoparticles as a promising approach. Martins et al. 
recently reported the chemo-sensitizing effect of apolar ecdys-
teroids on MDR cancer cells.10 The antiproliferative activity of 
these compounds was very low, and they exerted a mild activi-
ty in modulating the ABCB1-mediated efflux of rhodamine 
123. Further studies revealed that the chemo-sensitizing activi-
ty can be independent of efflux inhibition, in particular, ketals 
of poststerone, a known in vivo metabolite of 20-
hydroxyecdysone, sensitized ABCB1-transfected cancer cells 
to doxorubicin in a highly MDR selective manner without sig-
nificantly interfering with the efflux function. 
In this scenario we planned the preparation of some ecdysone 
conjugates containing the squalene tail to be combined with 
the known squalenoylated doxorubicin12 (Chart 1) and investi-
gate their ability to form hetero-nanoparticles (H-NPs) to-
wards the treatment of doxorubicin resistant cell lines. In the 
light of the synergistic effect of ecdysteroid acetonides with 
doxorubicin,10, we focused our attention on diketals of 20-
hydroxyecdysone and related derivatives of poststerone. 
 
  
Chart 1. Schematic representation of the building blocks and 
obtained conjugates.  
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Five different conjugates were prepared according to Schemes 
1 and 2 (see Supp. Info.). 20-Hydroxyecdysone derivatives 3a-
c were synthesized following a three-step procedure (Scheme 
1): a) condensation reaction between the protected 20-
hydroxyecdysone 1 and the proper acid 2, b) deprotection of 
the carboxylic group and c) final condensation with 1’,2-tris-
norsqualene alcohol. Compounds 6a and 6b were prepared by 








































b X=S  
Scheme 1. Synthesis of the conjugates 3a-c. 
 
 
Scheme 2. Synthesis of the conjugates 6a,b. 
 
Starting material X PG Deprotection Product 
1-diacetonide CH2 Bn H2, Pd(OH)2 3a 
1-di(cyclohexylacetal) CH2 Bn H2, Pd(OH)2 3b 
1-diacetonide S (CH2)2SiMe3 TBAF 3c 
4 CH2 - - 6a 
4 S - - 6b 
Table 1. Ecdysteroid conjugates and corresponding starting 
material. 
 
Next, the ability of the conjugates to self-assemble in nanopar-
ticles was investigated. Briefly, compound solution in THF 
was added dropwise into ultrapure water. The spontaneous 
self-assembly into NPs is a consequence of local interactions 
between the hydrophobic molecules, mainly guided by squa-
lene chains interactions. Subsequently, the organic solvent was 
removed under reduced pressure (see Supp. Info.). The nano-
suspensions were characterized by dynamic light scattering 
(DLS) and transmission electron microscopy (TEM). DLS 
analysis confirmed the formation of nanoassemblies in aque-
ous medium. The assemblies were monodisperse (PdI < 0.2) 
with sizes around 200 nm, except for the 6a NPs that exhibited 
a twofold larger hydrodynamic diameter (366.3 nm ± 20.17 
nm). The highly negative ζ-potential values (<−20.0 mV) sug-
gested that the electrostatic repulsion between NPs contributed 
to the stability of the nanoassemblies in aqueous medium. 
 
NPs h.d. ± S.D (nm) P.I. ζ-pot. ± S.D. (mV) 
3a 198.1 ± 0.9 0.106 ± 0.041 -49.8 ± 0.9 
3b 205.1 ± 0.6 0.050 ± 0.026 -43.0 ± 0.9 
3c 214 ± 3.4 0.086 ± 0.046 -30.0 ± 4.6 
6a 366.3 ± 20.17 0.161 ± 0.032 -21.5 ± 4.55 
6b 221.8 ± 4.879 0.081 ± 0.088 -21.7 ± 1.50 
Table 2. NPs characterization by dynamic light scattering 
(ZetaSizer, Malvern). h.d.: hydrodynamic diameter; P.I.: Pol-
ydispersity Index; ζ-pot.: ζ-potential. 
 
Compounds 3a-c and 6a,b were further mixed with squalene-
conjugated doxorubicine (DOXO-Sq) that is well known to 
have a better therapeutic index than doxorubicin12 and to form 
hetero-nanoparticles (H-NPs) according to our recent paper.7 
H-NPs were prepared by mixing the compound solutions (125 
µl, 250 µg, 2 mg ml-1) with DOXO-Sq solution (2 mg ml-1) in 
THF with a molar ratio compound/DOXO-Sq of 50 and by 
dropping the organic solution into 250 µl of ultrapure water as 
previously described. The mixture became opalescent suggest-
ing the possible formation of particles. H-NPs filtered with a 
0.45µm filter were characterized by DLS and TEM. DLS 
analysis (Table 3) confirmed the formation of H-NPs in aque-
ous medium. The assemblies were monodisperse (PdI < 0.2), 
but larger compared to the homogeneous NPs, except for the 
6a,b NPs where DOXO-Sq resulted in a decrease of (or did 
not alter) the particle dimension, respectively. Also, the ζ-
potential values decreased. 
 
X:DOXO-Sq 50:1 h.d. ± S.D      
(nm) 
P.I. ζ-pot.±S.D.    
(mV) X 
3a 533.1 ± 26.60 0.160 ± 0.104 - 9.73 ± 0.95 
3b 538.2 ± 33.41 n.d. - 9.39 ± 2.91 
3c 579.2 ± 104.4 0.226 ± 0.276 - 20.3 ± 2.52 
6a 187.7 ± 14.48 0.223 ± 0.069 -13.5 ± 9.65 
6b 298.7 ± 11.43 0.264 ± 0.014 -11.1 ± 3.48 
Table 3. H-NPs characterization by dynamic light scattering 
(ZetaSizer, Malvern). h.d.: hydrodinamic diameter, P.I.: Poly-
dispersity Index; ζ-pot.: ζ-potential. 
 
Figure 1 reports TEM analysis for NPs obtained by self-
assembly of compound 6b and the H-NPs 6b/DOXO-Sq 
(50:1). The images show compact nanoparticles whose diame-
ter is smaller if compared with the data obtained by DLS but 
similar in the case of H-NPs.  
 
                
 Figure 1. TEM analysis for NPs-6b (a, scale reported 1 µm) 
and H-NPs 6b/DOXO-Sq (b, scale reported 500 nm) 
 
The ability of both NPs and H-NPs to inhibit cell growth was 
assayed on A2780ADR cells, a human ovarian carcinoma 
doxorubicin-resistant cell line. The obtained results are shown 
in Table 4 and are expressed as GI50 values, i.e. the concentra-
tion of the test agent inducing 50% reduction in cell number 
compared with control cultures. 
 
 A2780-ADR cells (GI50, µM)
a
 
 NPs X:DOXO-Sq 50:1 
3a > 50 0.50 ± 0.02 
3b > 50 0.78 ± 0.02 
3c > 50 0.69 ± 0.15 
6a 19 ± 3 0.34 ± 0.08 
6b 39 ± 4 0.26 ± 0.03 
DOXO-Sq 1.17 ± 0.06 ---- 
Table 4. Inhibition of A2780ADR cell growth.. aValues are 










Page 2 of 5
ACS Paragon Plus Environment






























































Considering the NPs, it can be noted that DOXO-Sq exerts an 
interesting inhibitory effect on A2780ADR proliferation, 
showing a GI50 value of about 1 µM. This capacity, notwith-
standing about ten times lower with respect to that of doxoru-
bicin (GI50= 0.16 ± 0.01 µM) confirms, in accordance with 
previous studies,12 the ability of the drug to induce an antipro-
liferative effect even following squalenoylation. Otherwise, 
the NPs obtained by squalene-conjugated ecdysteroids pro-
voke in the same experimental conditions a negligible effect 
on cells and indeed, only for the nanoassemblies 6a and 6b a 
detectable and quite low cytotoxicity on A2780ADR cells was 
demonstrated. Notably, the H-NPs obtained by mixing 3a-c 
and 6a,b with DOXO-Sq induce a significant antiproliferative 
effect, with GI50 values from 1.5 to more than 4 times lower 
with respect to that obtained for DOXO-Sq. These data sug-
gest the ability of the H-NPs to overcome, at least partially, 
the resistance phenomenon. In this connection, it was of inter-
est to investigate the effect of tamoxifen, a well-known inhibi-
tor of the P-glycoprotein13 on the intracellular uptake of the H-
NPs 3a/DOXO-Sq, taken as an example, and of doxorubicin, 
used as reference. The cell internalization in A2780ADR was 
monitored by flow cytometry. As expected, the presence of 
tamoxifen significantly increased the drug accumulation in 
these cells. In detail, the intracellular mean fluorescence inten-
sity of doxorubicin rose by 27% after exposure to the P-
glycoprotein inhibitor. Otherwise, no difference in fluores-
cence was observed between the cells treated and those not-
treated with tamoxifen. This result further supports the hy-
pothesis that these new H-NPs can play a crucial role in drug 
resistance mechanism, suggesting the inability or at least the 
reduction of P-glycoprotein to mediate their efflux from re-
sistant cells. The in vitro cell internalization was then further 
investigated by fluorescence microscopy to verify any change 
in the uptake pathway. For this purpose, A2780ADR cells 
were incubated for two hours in the presence of doxorubicin 
and the  H-NPs 3a/DOXO-Sq. The results are shown in Fig-
ure 2a and 2b, respectively. 
  
 
Figure 2. Fluorescence microscopy of A2780ADR cells incu-
bated for 2h in the presence of doxorubicin (a) or H-NPs 
3a/DOXO-Sq (b) at 5 µM. The nucleus and cytoplasm were 
stained with DAPI and antibody anti-tubulin conjugated with 
AlexaFluor488, respectively. 
 
The cell penetration of both agents is rapid, nevertheless, the 
intracellular localization differs: for the drug a major localiza-
tion in the nuclei is observed (a), while for the H-NPs a stain-
ing almost exclusive in the cytoplasm appears (b). 
A more in depth microscopy analysis (Figure 3), highlights in 
the cytoplasm of A2780ADR cells treated with the H-NPs 
3a/DOXO-Sq, the occurrence of vesicles characterised by a 
mean diameter of about 0.9 µm, a value significantly higher 
with respect to the hydrodynamic diameter of the correspond-
ing H-NP (538.2 ± 33.41, Table 3). Such observation suggests 
that the H-NPs could enter into cell through an endosome-
mediated pathway, a mechanism already demonstrated for 















Figure 3. Fluorescence microscopy of A2780ADR cell treated 
for 2h with H-NPs 3a/DOXO-Sq.. 
 
The obtained results highlight the effectiveness of self-
assembled H-NPs to face cancer resistance and show a general 
strategy that could be applied in various pathologies where 
combined therapy could be beneficial. 
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The Supporting Information is available free of charge on the 
ACS Publications website. It contains the experimental details 
regarding: preparation of compounds 3a-c and 6a,b, nanoparticles 
preparation and characterization, biological evaluation. (cell cul-
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